Sonodynamic therapy, a treatment developing from photodynamic therapy

Liu, Rengeng; Zhang, Qianyu; Lang, Yuehong; Peng, Zhongzhong; Li, Libo

doi:10.1016/j.pdpdt.2017.06.003

Cited by 190 publications

(147 citation statements)

References 59 publications

Supporting

Mentioning

144

Contrasting

Unclassified

Order By: Relevance

“…Moreover, oceans of novel nanoparticles are currently under study and the systematically combination of varied nanomaterial will provide a very large number of options for selecting highly-specific and highly-efficient therapeutic nanovectors according to individual patient. On the other hands, to develop more selective and less toxic cancer therapies, nanoparticles have been applied to combine several therapeutic interventions, including photodynamic (Roblero-Bartolon & Ramon-Gallegos 2015; Agostinis et al 2011;Chatterjee et al 2008), sonodynamic (Xu et al 2016;Rengeng et al 2017) and radiotherapy (Hainfeld & Dilmanian 2010), etc., as sensitisers or imaging agent or both. The following sections will review the recent advance in the combination of nanoparticles with existing anti-cancer interventions.…”

Section: Dendrimersmentioning

confidence: 99%

“…(Roblero-Bartolon & Ramon-Gallegos 2015; Agostinis et al 2011;Chatterjee et al 2008). Nanoparticles that can absorb and/or transfer light energy and generate ROS by themselves after irradiation activation include TiO2 nanoparticles (Rengeng et al 2017), quantum dots (Chatterjee et al 2008), silicon nanoparticles (Agostinis et al 2011), silica nanoparticles (Kim et al 2017;W. H. Chen et al 2017) and conjugated polymer nanoparticles (Qian et al 2017), etc.…”

Section: Nano-sensitisersmentioning

confidence: 99%

“…There have been some promising nano materials developed as sonosensitizers, such as gold, TiO2, Fe3O4, Carbon fluoroxide, porous silicon, silver and silver copper nanoparticles, etc. (Xu et al 2016;Rengeng et al 2017) For instance, TiO2 nanoparticles, as an emerging nano material, also known as a photosensitizer, have high biocompatibility, great stability, small molecular weight and accessibility to cytomembrane. After being treated with ultrasound, the TiO2 NPs inside cells can generate active hydroxyl ions which can kill target cells in vitro and in animal models (Rengeng et al 2017).…”

Section: Sonosensitisersmentioning

confidence: 99%

“…(Xu et al 2016;Rengeng et al 2017) For instance, TiO2 nanoparticles, as an emerging nano material, also known as a photosensitizer, have high biocompatibility, great stability, small molecular weight and accessibility to cytomembrane. After being treated with ultrasound, the TiO2 NPs inside cells can generate active hydroxyl ions which can kill target cells in vitro and in animal models (Rengeng et al 2017). Chen et al have recently reported mitochondria targeting liposomes for sonosensitizer delivery .…”

Section: Sonosensitisersmentioning

confidence: 99%

See 3 more Smart Citations

Combination Strategies for Targeted Delivery of Nanoparticles for Cancer Therapy

He¹,

Liu²,

Byrne³

et al. 2019

Applications of Targeted Nano Drugs and Delivery Systems

View full text Add to dashboard Cite

Pharmaceuticals, and more recently biopharmaceuticals, have become the mainstay for antineoplastic treatments in combination with surgical interventions and radiation therapy. In recent years, advances have been made in the development of nanotechnological interventions for the treatment of cancer alone or in combination with existing therapeutic modalities. Nanotechnology used for therapeutic drug delivery and sensitization of photodynamic, sonodynamic and radiotherapy are now being tested in preclinical and clinical trials for the treatment of cancer. This article will review the current state of the art for nanotechnology therapies with an emphasis on targeted drug delivery and the observed and likely benefits when used in combination with existing therapeutic approaches.

show abstract

Section: Dendrimersmentioning

confidence: 99%

Section: Nano-sensitisersmentioning

confidence: 99%

Section: Sonosensitisersmentioning

confidence: 99%

Section: Sonosensitisersmentioning

confidence: 99%

See 2 more Smart Citations

Combination Strategies for Targeted Delivery of Nanoparticles for Cancer Therapy

He¹,

Liu²,

Byrne³

et al. 2019

Applications of Targeted Nano Drugs and Delivery Systems

View full text Add to dashboard Cite

show abstract

“…Sonodynamic therapy has been considered a promising noninvasive method for preclinical neoadjuvant treatment in recent decades. [1][2][3][4][5][6][7][8][9] The well-known mechanism of SDT oncotherapy is mainly via the sonosensitizer's ROS release, which is triggered by focused ultrasound and subsequently suppresses cell proliferation and causes cell apoptosis in the tumor. 10 Many active ingredients in traditional Chinese medicines have been recommended as reagents for SDT tumor therapy.…”

Section: Introductionmentioning

confidence: 99%

Berberine nanoparticles for promising sonodynamic therapy of a HeLa xenograft tumour

et al. 2019

View full text Add to dashboard Cite

show abstract

Sono/Photodynamic Nanomedicine‐Elicited Cancer Immunotherapy

Xie

et al. 2020

Adv Funct Materials

View full text Add to dashboard Cite

Immunotherapy (e.g., cancer vaccines and checkpoint blockades), harnessing the host immune system to recognize and eradicate tumors, has emerged as one of the most potent cancer therapies. The clinical applications of cancer immunotherapies, however, have been limited by their low response rates and immune‐related adverse effects. In recent years, sono/photodynamic nanomedicines (SPNs) have received increasing attention for cancer therapy since they have been reported to mediate enhanced immunotherapy by generating reactive oxygen species under site‐specific exposure to exogenous energy sources. In particular, SPNs are capable of eliciting immunogenic cancer cell death, leading to the release of tumor‐associated antigens and damage‐associated molecular patterns. This allows for the maturation of antigen‐presenting cells, thus eliminating disseminated or metastatic tumor cells by cytotoxic CD8+ T cells. Such immunostimulatory features of SPNs provide opportunities to enhance therapeutic potential by amplifying anticancer immunity when combined with conventional immunotherapeutics, including immune checkpoint inhibitors. This review elaborates on the recent strategies and efforts undertaken by researchers to enhance SPN‐elicited cancer immunotherapy. The challenging issues and opportunities for SPNs in the activation of innate or adaptive immune responses and regulation of the tumor immunosuppressive microenvironment are also described.

show abstract

Sonodynamic therapy, a treatment developing from photodynamic therapy

Cited by 190 publications

References 59 publications

Combination Strategies for Targeted Delivery of Nanoparticles for Cancer Therapy

Combination Strategies for Targeted Delivery of Nanoparticles for Cancer Therapy

Berberine nanoparticles for promising sonodynamic therapy of a HeLa xenograft tumour

Sono/Photodynamic Nanomedicine‐Elicited Cancer Immunotherapy

Contact Info

Product

Resources

About